Value in Health Special Issue: Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries
This special issue of Value in Health showcases presentations made at the Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the U.S. and Other Countries symposium held on May 15, 2009.
Articles in this issue include the following:
- Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries (pages S1–S3), Adrian R. Levy and Louis P. Garrison Jr.
- Health Technology Assessment in the United Kingdom (pages S4–S5), Ron Akehurst
- Health Technology Assessment and Comparative Effectiveness in Sweden (pages S6–S7), Egon Jonsson
- Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario (pages S8–S11), Ron Goeree, Kiran Chandra, Jean-Eric Tarride, Daria O'Reilly, Feng Xie, James Bowen, Gord Blackhouse and Robert Hopkins
- Comparative Assessment for Medications and Devices: Apples and Oranges? (pages S12–S14), Scott Ramsey
- Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis (pages S15–S17), Edward J. Mills
- Reflecting Heterogeneity in Patient Benefits: The Role of Subgroup Analysis with Comparative Effectiveness (pages S18–S21), Mark Sculpher
- Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries (pages S22–S25), Andrew Briggs
- Experimental and Observational Data and Formulary Listing (pages S26–S29), Raulo S. Frear
- Net Clinical Benefit: The Art and Science of Jointly Estimating Benefits and Risks of Medical Treatment (pages S30–S32), Adrian Towse
Due to copyright issues, articles must be accessed through the Value in Health website. NPC has limited print copies available for order.